358 related articles for article (PubMed ID: 24458747)
1. Influence of divergent exercise contraction mode and whey protein supplementation on atrogin-1, MuRF1, and FOXO1/3A in human skeletal muscle.
Stefanetti RJ; Lamon S; Rahbek SK; Farup J; Zacharewicz E; Wallace MA; Vendelbo MH; Russell AP; Vissing K
J Appl Physiol (1985); 2014 Jun; 116(11):1491-502. PubMed ID: 24458747
[TBL] [Abstract][Full Text] [Related]
2. Effects of divergent resistance exercise contraction mode and dietary supplementation type on anabolic signalling, muscle protein synthesis and muscle hypertrophy.
Rahbek SK; Farup J; Møller AB; Vendelbo MH; Holm L; Jessen N; Vissing K
Amino Acids; 2014 Oct; 46(10):2377-92. PubMed ID: 25005782
[TBL] [Abstract][Full Text] [Related]
3. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
[TBL] [Abstract][Full Text] [Related]
4. Regulation of ubiquitin proteasome pathway molecular markers in response to endurance and resistance exercise and training.
Stefanetti RJ; Lamon S; Wallace M; Vendelbo MH; Russell AP; Vissing K
Pflugers Arch; 2015 Jul; 467(7):1523-1537. PubMed ID: 25104573
[TBL] [Abstract][Full Text] [Related]
5. Positive muscle protein net balance and differential regulation of atrogene expression after resistance exercise and milk protein supplementation.
Reitelseder S; Agergaard J; Doessing S; Helmark IC; Schjerling P; van Hall G; Kjaer M; Holm L
Eur J Nutr; 2014 Feb; 53(1):321-33. PubMed ID: 23640273
[TBL] [Abstract][Full Text] [Related]
6. Expression patterns of atrogenic and ubiquitin proteasome component genes with exercise: effect of different loading patterns and repeated exercise bouts.
Nedergaard A; Vissing K; Overgaard K; Kjaer M; Schjerling P
J Appl Physiol (1985); 2007 Nov; 103(5):1513-22. PubMed ID: 17690190
[TBL] [Abstract][Full Text] [Related]
7. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway.
Wang XJ; Xiao JJ; Liu L; Jiao HC; Lin H
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046370
[TBL] [Abstract][Full Text] [Related]
8. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism.
Smith IJ; Alamdari N; O'Neal P; Gonnella P; Aversa Z; Hasselgren PO
Int J Biochem Cell Biol; 2010 May; 42(5):701-11. PubMed ID: 20079455
[TBL] [Abstract][Full Text] [Related]
9. Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients.
Léger B; Senese R; Al-Khodairy AW; Dériaz O; Gobelet C; Giacobino JP; Russell AP
Muscle Nerve; 2009 Jul; 40(1):69-78. PubMed ID: 19533653
[TBL] [Abstract][Full Text] [Related]
10. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
11. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.
Doucet M; Russell AP; Léger B; Debigaré R; Joanisse DR; Caron MA; LeBlanc P; Maltais F
Am J Respir Crit Care Med; 2007 Aug; 176(3):261-9. PubMed ID: 17478621
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of inducible nitric oxide synthase attenuates immobilization-induced skeletal muscle atrophy in mice.
Bae SK; Cha HN; Ju TJ; Kim YW; Kim HS; Kim YD; Dan JM; Kim JY; Kim SD; Park SY
J Appl Physiol (1985); 2012 Jul; 113(1):114-23. PubMed ID: 22518831
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the FoxO1/MuRF1/Atrogin-1 Signaling Pathway in the Oxidative Stress-Induced Atrophy of Cultured Chronic Obstructive Pulmonary Disease Myotubes.
Pomiès P; Blaquière M; Maury J; Mercier J; Gouzi F; Hayot M
PLoS One; 2016; 11(8):e0160092. PubMed ID: 27526027
[TBL] [Abstract][Full Text] [Related]
14. No differential effects of divergent isocaloric supplements on signaling for muscle protein turnover during recovery from muscle-damaging eccentric exercise.
Rahbek SK; Farup J; de Paoli F; Vissing K
Amino Acids; 2015 Apr; 47(4):767-78. PubMed ID: 25559753
[TBL] [Abstract][Full Text] [Related]
15. [The role of Foxo1 and ubiquitin-proteasome system markers in muscle atrophy caused by chronic kidney disease].
Yin J; Huang J; Yuan W; Gu L; Wang L; Shang M
Zhonghua Nei Ke Za Zhi; 2014 Jan; 53(1):31-4. PubMed ID: 24674725
[TBL] [Abstract][Full Text] [Related]
16. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
[TBL] [Abstract][Full Text] [Related]
17. Time course of proteolytic, cytokine, and myostatin gene expression after acute exercise in human skeletal muscle.
Louis E; Raue U; Yang Y; Jemiolo B; Trappe S
J Appl Physiol (1985); 2007 Nov; 103(5):1744-51. PubMed ID: 17823296
[TBL] [Abstract][Full Text] [Related]
18. Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle.
Frost RA; Nystrom GJ; Jefferson LS; Lang CH
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E501-12. PubMed ID: 17003238
[TBL] [Abstract][Full Text] [Related]
19. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
[TBL] [Abstract][Full Text] [Related]
20. Muscle protein breakdown has a minor role in the protein anabolic response to essential amino acid and carbohydrate intake following resistance exercise.
Glynn EL; Fry CS; Drummond MJ; Dreyer HC; Dhanani S; Volpi E; Rasmussen BB
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R533-40. PubMed ID: 20519362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
